Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Astellas Pharma Inc
Astellas Pharma Inc
University of Kentucky
Elevation Oncology
Leap Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoffmann-La Roche
Imugene Limited
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
NantBioScience, Inc.
Imunon
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Hoosier Cancer Research Network
Columbia University
Sumitomo Pharma America, Inc.
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Celgene
Karyopharm Therapeutics Inc
Daiichi Sankyo
Daiichi Sankyo
Organon and Co
Washington University School of Medicine
M.D. Anderson Cancer Center
University of Florida
University of Florida
Navidea Biopharmaceuticals
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Merck KGaA, Darmstadt, Germany
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Yale University
GlaxoSmithKline
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
Mauna Kea Technologies
Mauna Kea Technologies
BioVex Limited